Features of Top Medical Device Companies

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at DeviceTalks

July 1, 2014 by Brian Johnson

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

MassDevice.com sat down with Stacy Enxing Seng, executive in residence at Covidien (NYSE:COV), just a week after the company announced it had agreed to be acquired by Medtronic (NYSE:MDT) for $43 billion.

FDA cybersecurity rejections are on the way

June 5, 2014 by Arezu Sarvestani

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

FDA cybersecurity rejections are on the way

Although the FDA has only recently begun addressing medical device cybersecurity in an official capacity, device makers would do well to take notice that the agency has ramped up its oversight quickly over the last year.

Brian Walsh looks to transcend glaucoma treatment with CyPass micro-stent

June 2, 2014 by Brad Perriello

Transcend Medical CEO Brian Walsh tells MassDevice.com why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Brian Walsh looks to transcend glaucoma treatment with micro-stent

Until recently, the treatment for glaucoma – a group of diseases that cause pressure within the eyeball – consisted of several options, none of them ideal. Patients could opt for medicines, either oral or via eyedrops, to lower eye pressure. A surgical option that in essence creates a drain in the eyeball for ocular fluid is also available, as is a procedure call laser trabeculoplasty that also creates a drainage pathway.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Integrity Applications looks beyond optical for blood glucose

May 28, 2014 by Brad Perriello

Integrity Applications looks beyond optical sensors with its GlucoTrack Model DF-F, which uses ultrasonic, electromagnetic and thermal technology to measure physiological changes associated with blood glucose levels.

Diabetes: Integrity Applications looks beyond optical for blood glucose

A 23-year career in the Israeli Navy might not seem like the ideal background for a medical device company chief, but for Integrity Applications chairman & CEO Avner Gal it turned out to be the perfect pedigree.

Backboard to boardroom: Jonathan Bender's journey from NBA star to medtech entrepreneur

May 26, 2014 by Brian Johnson

Former NBA player Jonathan Bender tries his hand at entrepreneurship, aiming to bring the physical therapy device he invented to the U.S. market.

JB photo

Joint pain cut years from Jonathan Bender's professional basketball career, but it also gave him a future.

The former NBA player, who made the jump from high school directly to the pros in 1999, spent 7 injury-plagued seasons with the Indiana Pacers before bowing out in 2006 (Bender returned in 2010 for a half season with the New York Knicks).

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Engineering disruption: R&D firm Battelle pulls inspiration from surprising sources

May 23, 2014 by Arezu Sarvestani

Battelle engineering manager Melissa Masters tells MassDevice.com how insights ranging from national security to aeronautics can inform the creation of disruptive new medical devices.

Turning diversification into disruption: Battelle pulls inspiration from surprising sources

Medical device executives and Ted Talk-ers love comparing the medtech industry to consumer electronics or aeronautics when making grand points about the market, but at Battelle cross-industry correlations speak to the core of the company’s engineering philosophy.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ora aims to be your one-stop ophthalmology shop

May 21, 2014 by Brad Perriello

The special sauce in contract research organization Ora Inc.'s recipe for ophthalmology trials is the eye care practice its founder started 30 years ago.

Ora aims to be your one-stop ophthalmology shop

There's a special sauce in the recipe Ora Inc. uses to run clinical trials for ophthalmology devices and drugs that can reduce the time needed for a study from 6 months to 2 days: The eye care practice started by Ora founder Dr. Mark Abelson.

An ophthalmologist and optometric scientist and fellow at the Mass. Eye & Ear Infirmary, Abelson founded Andover Eye in 1978, his son Stuart Abelson – now Andover, Mass.-based Ora's CEO – told MassDevice.com.

Animals in labs: PETA's long history with the medtech industry

May 19, 2014 by Arezu Sarvestani

Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.

PETA targets Medtronic, Boston Scientific for animal experiments

Animal rights activists have long raised concerns about some of the largest medical device companies, taking up minuscule stock holdings to gain access to shareholder meetings at a raft of medtech makers.

Silicon Valley in-depth: Tapping medtech's Big Data with AliveCor CEO Euan Thomson

May 16, 2014 by Arezu Sarvestani

AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.

In depth in Silicon Valley: Mobile health and medtech's digital future with AliveCor CEO Euan Thomson

When Euan Thomson left Accuray (NSDQ:ARAY) in 2012 after more than 10 years, it wasn't so much for greener pastures as it was for swifter currents.

Medtronic exec: Google looms large as next great rival

May 7, 2014 by Brian Johnson

Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in the medical technology space in coming years.

Medtronic exec: Google looms large as next great rival

As Medtronic's  (NYSE:MDT) resident technology scout and visionary, Dr. Stephen Oesterle's job is to challenge the status quo at the world's largest pure-play medical device company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp